摘要
嘌呤ATP有著名的监管作用,中枢神经系统功能和病理对胶质细胞由于其操作——小胶质细胞,星形胶质细胞和少突胶质细胞。ATP作为显然无处不在的“gliotransmitter”所发布的星形胶质细胞和其他细胞嘌呤受体激活邻近细胞。在病理学,ATP的释放中转组织损伤和修复由其直接作用于神经胶质细胞完整性和生存。ATP在神经胶质的行为是通过广泛的受体介导,大致分为ionotropic P2X和metabotropic(g蛋白耦合受体(GPCR))P2Y受体,其中有多个亚型(P2X1-P2X7和P2Y1-P2Y14)。ATP-mediated星形胶质细胞和小胶质细胞之间的相互作用在中枢神经系统的免疫反应的中心,突出角色P2X4,P2X7,P2Y1,P2Y6 P2Y12受体亚型。少突胶质细胞,P2X7 P2Y1受体亚型分别由两部分构成的函数在调停少突细胞破坏和保护。嘌呤受体调节胶质病理学,突出角色在缺血、神经炎症,多个Scelerosis、神经性疼痛和创伤性损伤。值得注意的是,神经胶质ATP信号可能与衰老和改变与髓鞘形成障碍和免疫在阿尔茨海默氏症。因此,胶质嘌呤受体在多种神经病理学提供潜在的治疗靶点,但Jeckyll和海德嘌呤信号的本质突显出进一步的研究的重要性,全面了解角色不同嘌呤受体在介导的组织损伤和修复。
关键词: 神经胶质. 星形胶质细胞. 少突胶质细胞.ATP. 嘌呤受体
图形摘要
Current Drug Targets
Title:A Central Role for ATP Signalling in Glial Interactions in the CNS
Volume: 17 Issue: 16
Author(s): Andrea Rivera, Ilaria Vanzulli, Arthur M. Butt
Affiliation:
关键词: 神经胶质. 星形胶质细胞. 少突胶质细胞.ATP. 嘌呤受体
摘要: The purine ATP has a prominent regulatory role in CNS function and pathology due to its actions on glial cells - microglia, astrocytes and oligodendrocytes. ATP serves as an apparently ubiquitous ‘gliotransmitter’ that is released by astrocytes and other cells to activate purine receptors on neighbouring cells. In pathology, the release of ATP mediates both tissue damage and repair by its direct effects on glial cell integrity and survival. The actions of ATP on glia are mediated via a wide range of receptors, broadly divided into ionotropic P2X and metabotropic (G-protein coupled receptors (GPCR)) P2Y receptors, of which there are multiple subtypes (P2X1-P2X7 and P2Y1-P2Y14). ATP-mediated interactions between astrocytes and microglia are at the centre of immune responses in the CNS, with prominent roles for the P2X4, P2X7, P2Y1, P2Y6 and P2Y12 receptor subtypes. In oligodendrocytes, P2X7 and P2Y1 receptor subtypes have a bipartite function in respectively mediating oligodendrocyte destruction and protection. Purine receptors mediate glial pathology, with prominent roles in ischemia, neuroinflammation, Multiple Scelerosis, neuropathic pain and traumatic injury. Notably, glial ATP signalling may be altered with ageing and is implicated in impaired myelination and immunity in Alzheimer’s disease. Hence, glial purine receptors provide potential therapeutic targets in multiple neuropathologies, but the ‘Jeckyll and Hyde’ nature of purine signalling underscores the importance of further research and a comprehensive understanding of the roles of the different purine receptors in mediating tissue damage and repair.
Export Options
About this article
Cite this article as:
Andrea Rivera, Ilaria Vanzulli, Arthur M. Butt , A Central Role for ATP Signalling in Glial Interactions in the CNS, Current Drug Targets 2016; 17 (16) . https://dx.doi.org/10.2174/1389450117666160711154529
DOI https://dx.doi.org/10.2174/1389450117666160711154529 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects
Current Alzheimer Research Nitric Oxide Synthases and Their Natural Inhibitors
Current Enzyme Inhibition Parasite Prolyl Oligopeptidases and the Challenge of Designing Chemotherapeuticals for Chagas Disease, Leishmaniasis and African Trypanosomiasis
Current Medicinal Chemistry Effects of PPARγ Ligands on Vascular Tone
Current Molecular Pharmacology Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Targeting Vascular Neural Network in Intracerebral Hemorrhage
Current Pharmaceutical Design Characterization of Endogenous Neural Progenitor Cells after Experimental Ischemic Stroke
Current Neurovascular Research Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Current Molecular Pharmacology Adenosine in the Inflamed Gut: A Janus Faced Compound
Current Medicinal Chemistry NADPH Oxidase and Neurodegeneration
Current Neuropharmacology MicroRNA-451 Aggravates Kainic Acid-induced Seizure and Neuronal Apoptosis by Targeting GDNF
Current Neurovascular Research Editorial [Hot Topic: Bringing Drugs Into the Injured Brain and Keeping Them There (Executive Guest Editors: Dirk M. Hermann and Pauline Patak)]
Current Pharmaceutical Design Tau Truncation is a Productive Posttranslational Modification of Neurofibrillary Degeneration in Alzheimer’s Disease
Current Alzheimer Research Oral Agents in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pharmacological Approach of Pistacia Vera Fruit to Assess Learning and Memory Potential in Chemically-Induced Memory Impairment in Mice
Central Nervous System Agents in Medicinal Chemistry Anti-Hypertensive Potential and Epigenetics of Angiotensin II type 2 Receptor (AT2R)
Current Hypertension Reviews Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders
Current Pharmaceutical Design Neurotuberculosis: An Overview
Central Nervous System Agents in Medicinal Chemistry Interleukin-1 Drives Cerebrovascular Inflammation via MAP Kinase-Independent Pathways
Current Neurovascular Research